CO5170420A1 - Nuevos farmacos hidrocloruro - Google Patents

Nuevos farmacos hidrocloruro

Info

Publication number
CO5170420A1
CO5170420A1 CO00028928A CO00028928A CO5170420A1 CO 5170420 A1 CO5170420 A1 CO 5170420A1 CO 00028928 A CO00028928 A CO 00028928A CO 00028928 A CO00028928 A CO 00028928A CO 5170420 A1 CO5170420 A1 CO 5170420A1
Authority
CO
Colombia
Prior art keywords
pharmacos
mfi
jpeg
provides
new hydrochloride
Prior art date
Application number
CO00028928A
Other languages
English (en)
Inventor
Gompel Paul David James
Robert Gordon Giles
Michael John Sasse
Andrew Simon Craig
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of CO5170420A1 publication Critical patent/CO5170420A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

El monohidrato de hidrocloruro de 5-[4-[2-(N-metil-N- (2-piridil)amino)etoxi]bencil]tiazolidina-2,4-diona de fórmula<EMI FILE="00028928_1" ID="1" IMF=JPEG >caracterizado porque:(i) proporciona un espectro infrarrojo que contiene picos a 3.392, 2.739, 1.751, 1.325 y 713 cm-1; y/o (ii) proporciona un modelo de difracción de rayos X a través de polvo (XRPD) que contiene picos a 9,1, 12,0, 15,7, 16,3 y 19,8°2?.<EMI FILE="00028928_2" ID="2" IMF=JPEG >
CO00028928A 1999-04-20 2000-04-19 Nuevos farmacos hidrocloruro CO5170420A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9909075.5A GB9909075D0 (en) 1999-04-20 1999-04-20 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
CO5170420A1 true CO5170420A1 (es) 2002-06-27

Family

ID=10851922

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00028928A CO5170420A1 (es) 1999-04-20 2000-04-19 Nuevos farmacos hidrocloruro

Country Status (42)

Country Link
EP (2) EP1411054A1 (es)
JP (2) JP4283450B2 (es)
KR (1) KR100677815B1 (es)
CN (2) CN1327446A (es)
AP (1) AP1680A (es)
AR (2) AR023563A1 (es)
AT (1) ATE262524T1 (es)
AU (1) AU773112B2 (es)
BG (1) BG65428B1 (es)
BR (1) BR0009898A (es)
CA (1) CA2370270A1 (es)
CO (1) CO5170420A1 (es)
CZ (1) CZ300934B6 (es)
DE (1) DE60009276T2 (es)
DK (1) DK1173437T3 (es)
DZ (1) DZ3163A1 (es)
EA (1) EA004769B1 (es)
EG (1) EG23946A (es)
ES (1) ES2214267T3 (es)
GB (1) GB9909075D0 (es)
HK (1) HK1045304B (es)
HR (1) HRP20010771B1 (es)
HU (1) HUP0200785A3 (es)
IL (1) IL146077A0 (es)
MA (1) MA26784A1 (es)
MX (1) MXPA01010695A (es)
MY (1) MY125209A (es)
NO (1) NO320573B1 (es)
NZ (1) NZ515164A (es)
OA (1) OA11867A (es)
PE (1) PE20010047A1 (es)
PL (1) PL351115A1 (es)
PT (1) PT1173437E (es)
RS (1) RS50137B (es)
SI (1) SI1173437T1 (es)
SK (1) SK284990B6 (es)
TR (1) TR200103041T2 (es)
TW (1) TWI291463B (es)
UA (1) UA72245C2 (es)
UY (1) UY26113A1 (es)
WO (1) WO2000063206A2 (es)
ZA (1) ZA200108721B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9909075D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
GB0006133D0 (en) 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
GB0014005D0 (en) * 2000-06-08 2000-08-02 Smithkline Beecham Plc Novel pharmaceutical
DK1448559T3 (da) * 2001-11-21 2007-04-30 Smithkline Beecham Plc 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl)thiazolodin-2,4-dionbenzensulfat; fremgangsmåde til dets fremstilling; polymorf i, II og III deraf; og dets anvendelse som farmaceutisk aktiv bestenddel
KR100450700B1 (ko) * 2002-03-22 2004-10-01 주식회사종근당 티아졸리딘디온 유도체 화합물 및 이를 함유하는 약제학적조성물
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
EP1842850A1 (en) * 2006-03-23 2007-10-10 Sandoz AG Rosiglitazone hydrochloride hemihydrate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842925A1 (en) * 1987-09-04 1998-05-20 Beecham Group Plc Substituted thiazolidinedione derivatives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9909075D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
DK1173437T3 (da) 2004-07-12
DZ3163A1 (fr) 2000-10-26
HK1045304A1 (en) 2002-11-22
AP1680A (en) 2006-11-27
BR0009898A (pt) 2002-04-16
NO320573B1 (no) 2005-12-27
YU81601A (sh) 2004-09-03
JP4283450B2 (ja) 2009-06-24
HUP0200785A2 (en) 2002-08-28
JP2002542243A (ja) 2002-12-10
GB9909075D0 (en) 1999-06-16
DE60009276T2 (de) 2004-08-26
HUP0200785A3 (en) 2004-03-29
RS50137B (sr) 2009-03-25
HRP20010771B1 (en) 2005-06-30
ZA200108721B (en) 2002-09-13
CA2370270A1 (en) 2000-10-26
TR200103041T2 (tr) 2002-03-21
CN1327446A (zh) 2001-12-19
DE60009276D1 (de) 2004-04-29
AR023563A1 (es) 2002-09-04
CN101125851A (zh) 2008-02-20
JP2009161544A (ja) 2009-07-23
PT1173437E (pt) 2004-06-30
SK284990B6 (sk) 2006-04-06
WO2000063206A2 (en) 2000-10-26
WO2000063206A3 (en) 2001-02-22
KR20010112446A (ko) 2001-12-20
OA11867A (en) 2006-03-02
EG23946A (en) 2008-01-22
EP1411054A1 (en) 2004-04-21
CZ20013758A3 (cs) 2003-05-14
HRP20010771A2 (en) 2002-12-31
MXPA01010695A (es) 2002-06-04
UA72245C2 (uk) 2005-02-15
CZ300934B6 (cs) 2009-09-16
EP1173437B1 (en) 2004-03-24
EP1173437A2 (en) 2002-01-23
MA26784A1 (fr) 2004-12-20
AP2001002332A0 (en) 2001-12-31
AR023567A1 (es) 2002-09-04
AU4131100A (en) 2000-11-02
PL351115A1 (en) 2003-03-24
TWI291463B (en) 2007-12-21
SI1173437T1 (en) 2004-06-30
UY26113A1 (es) 2000-12-29
BG106120A (en) 2002-05-31
NO20015105L (no) 2001-12-19
ATE262524T1 (de) 2004-04-15
EA004769B1 (ru) 2004-08-26
KR100677815B1 (ko) 2007-02-05
BG65428B1 (bg) 2008-07-31
NZ515164A (en) 2004-02-27
PE20010047A1 (es) 2001-03-10
ES2214267T3 (es) 2004-09-16
NO20015105D0 (no) 2001-10-19
EA200101102A1 (ru) 2002-04-25
AU773112B2 (en) 2004-05-20
MY125209A (en) 2006-07-31
HK1045304B (zh) 2004-12-24
IL146077A0 (en) 2002-07-25
SK14892001A3 (sk) 2002-02-05

Similar Documents

Publication Publication Date Title
CO5170421A1 (es) Nuevo compuesto farmaceutico maleico
PL329884A1 (en) 5-{2-[4-(1,2-benzoisothiazol-3-yl)-1 piperasinyl] ethyl}-6-chloro-1,3-dihydro-2h-indol-2-one(ziprasidone) mesilan dihydrates, method of obtaining them and their applications as antagonists of dopamine d2
CO5170422A1 (es) Nuevos compuestos antidiabeticos con base en hidrato de hidrocloruro
MY135770A (en) Novel pharmaceutical
CY1106226T1 (el) Μεσυλικο αλας 5-[4-[2-(ν-μεθυλ-ν-(2-πυριδυλ)αμινο)αιθοξυ]βενζυλ]θειαζολιδινο-2,4-διονης
CO5170420A1 (es) Nuevos farmacos hidrocloruro
CO5170419A1 (es) Nuevo compuesto antidiabetico con base en sales del acido maleico
IL133074A0 (en) Composition comprising 5-[4-[2-(n-methyl-n-2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione
AU2002343036A1 (en) 5-(4-(2-(n-methyl-n-(2-pyridyl)amido)ethoxy)benzyl)thiazolidine-2,4-dione and pharmaceutical compositions comprising the same
AP1715A (en) The hydrochloride salt of 5-[ 4 -[2 -(n-methyl-n- (2-pyridyl) amino) ethoxy]benzyl]thiazolidine -2,4-dione
AP1600A (en) Combination of a thiazolidinedione and a sulphonylurea for treating diabetes
DE60212434D1 (de) Rosiglitazon-edisylate und ihre verwendung als antidiabetika
GB0021784D0 (en) Novel pharmaceutical
GB0021978D0 (en) Novel pharmaceutical
ECSP003434A (es) Nuevos compuestos
AP2002002684A0 (en) 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical
CY1107767T1 (el) Παραγωγο θειαζολιδινοδιονης και χρηση αυτου σαν αντιδιαβητικο
IL160144A0 (en) Composition comprising 5-[4-[2-(n-methyl-n-2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2, 4-dione

Legal Events

Date Code Title Description
FC Application refused